1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Shanghai Chest HospitalNot specified NCT07045532 Registry history of NCT07045532 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-21 | NCT07830095 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary… | Not Yet Recruiting | |
| 2026-09-21 | NCT07830355 Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With… | Phase 2 | Not Yet Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 5 | |
| Phase 2 | 26 | |
| Phase 2/3 | 2 | |
| Phase 3 | 2 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06483009 | Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With… | Non-Small-Cell Lung Cancer | Not Yet Recruiting | 2024-08-30 |
| Phase 3 | ||||
| NCT06437977 | Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable… | Stage II-III Non-small Cell Lung Cancer | Recruiting | 2026-05-13 |
| NCT04135664 | Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage… | Esophageal Cancer | Recruiting | 2019-10-22 |
| Phase 2/3 | ||||
| NCT07662811 | SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for… | Non-Small Cell Lung Cancer | Not Yet Recruiting | 2026-06-29 |
| NCT07076693 | Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With… | OligoProgressive Metastatic Disease | Active, Not Recruiting | 2025-07-22 |
| Phase 2 | ||||
| NCT07811752 | Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic… | Esophageal Squamous Cell Carcinoma | Recruiting | 2026-09-10 |
| NCT07091305 | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy… | Limited-stage Small Cell Lung Cancer (LS-SCLC) | Recruiting | 2026-06-11 |
| NCT05798845 | The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+)… | NSCLC | Recruiting | 2026-03-11 |
| NCT05978193 | Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell… | Esophageal Squamous Cell Carcinoma | Recruiting | 2026-01-22 |
| NCT07357623 | Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary… | Pulmonary Neuroendocrine Tumor | Recruiting | 2026-01-22 |
| NCT07058519 | A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC | Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) | Recruiting | 2025-11-26 |
| NCT06127303 | Toripalimab Combined With Cryoablation for First-line Oligo-progression in… | Non-small Cell Lung Cancer | Recruiting | 2025-09-05 |
| NCT06659042 | Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small… | Lung Cancer, Non-Small Cell | Recruiting | 2025-05-18 |
| NCT06709417 | A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent… | Esophageal Squamous Cell Carcinoma (ESCC) | Recruiting | 2024-11-29 |
| NCT06698965 | Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer… | Lung Cancer, Small Cell | Recruiting | 2024-11-21 |
| NCT06385730 | Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) | Esophageal Cancer | Recruiting | 2024-07-01 |
| NCT07830355 | Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With… | Esophageal Squamous Cell Carcinoma | Not Yet Recruiting | 2026-09-21 |
| NCT07549061 | Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC | Lung Neoplasms | Not Yet Recruiting | 2026-04-29 |
| NCT07479628 | Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma | Thymic Carcinoma | Not Yet Recruiting | 2026-03-18 |
| NCT05751187 | Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients | Non-squamous NSCLC | Active, Not Recruiting | 2026-03-11 |
| NCT05621707 | Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced… | Esophageal Squamous Cell Carcinomas | Active, Not Recruiting | 2026-02-02 |
| NCT07281209 | A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable… | NSCLC | Not Yet Recruiting | 2025-12-15 |
| NCT07261098 | The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent… | Advanced Lung Cancer | Not Yet Recruiting | 2025-12-03 |
| NCT04504071 | Dacomitinib in Lung Cancer With Uncommon EGFR Mutations | Non-small Cell Lung Cancer Metastatic | Active, Not Recruiting | 2025-09-08 |
| NCT05078931 | A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC… | NSCLC | Active, Not Recruiting | 2025-07-30 |
Lung Cancer (54) · Non-Small Cell Lung Cancer (NSCLC) (32) · Esophageal Cancer (12) · Heart Disease (12) · Atrial Fibrillation (9) · Small Cell Lung Cancer (4) · COPD (1) · Heart Failure (1)